Iridius.ai, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Iridius.ai, Inc. - overview

Established

2024

Location

Seattle, WA, US

Primary Industry

Software

About

Based in the US, Iridius. ai, Inc. offers innovative compliance-driven artificial intelligence solutions that integrate regulatory requirements into operational workflows for regulated industries. Iridius.


ai, Inc. is focused on providing artificial intelligence solutions tailored for enterprises in regulated sectors. Founded in 2024 in Seattle, US, the company has completed 1 deal, with its most recent funding round occurring on March 31, 2026. The company raised USD 8.


6 mn in Seed funding led by Chalfen Ventures, with participation from Accenture Technology Ventures, Osage Venture Partners, and Rock Yard Ventures, bringing the total amount raised to USD 8. 6 mn. The founder's history and prior ventures are not specified. Iridius specializes in compliance-driven artificial intelligence solutions tailored for regulated enterprises.


The company's core product offering transforms regulatory standards into executable logic, embedding compliance directly within AI workflows. This integration ensures that evidence is generated continuously as systems operate, addressing challenges faced by organizations in regulated environments where safety, regulatory, and clinical tools often lack interoperability. Iridius's solutions are deployed in various sectors, including pharmacovigilance, regulatory submissions, and clinical development, targeting clients who require stringent compliance with GxP (Good Practice) regulations. The company serves a diverse clientele across North America, Europe, and Asia, where enterprises seek to harmonize AI implementation with compliance requirements.


Iridius's revenue structure is primarily based on subscription models for its compliance-enabling AI solutions, facilitating ongoing partnerships with regulated enterprises. Clients engage with Iridius through direct business-to-business transactions, subscribing to the company's services for compliance automation and workflow management. This subscription model allows organizations to access Iridius's patented technology and tailored support, ensuring continuous compliance readiness. Specific pricing plans for these services are structured to reflect the complexity and scale of the client's operational needs, although detailed pricing information is not disclosed.


This structured approach fosters long-term client relationships and positions Iridius as a key player in helping organizations navigate the intricate landscape of regulatory compliance. Iridius. ai plans to utilize its recent funding of USD 8. 6 mn from the Seed round to expand operations and enhance its AI-driven workflows.


The company aims to develop new product offerings designed for enhanced compliance automation and workflow efficiency. Furthermore, Iridius intends to enter new geographic markets, focusing on the Asia-Pacific region by 2027, to meet the growing demand for compliance solutions in those areas.


Current Investors

Accenture Technology Ventures, Osage Venture Partners, Chalfen Ventures

Primary Industry

Software

Sub Industries

Healthcare IT, Monitoring & Security Software

Website

www.iridius.ai/

Verticals

Artificial Intelligence, Cloud Computing, HealthTech, RegTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.